| Tretinoin studied in …STUDIED_INderived102 of 102show fewer |
|---|
| → studied in | NCT07842887Phase 1 · not yet recruiting Phase 1 Study of ATRA Plus a PD-1 Inhibitor in EGFR-Mutant NSCLC After Third-Generation EGFR-TKI Resistance · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305041Phase 1/Phase 2 · completed Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02) · 102 trials list this drug (23 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04303169Phase 1/Phase 2 · completed Substudy 02C: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Stage III Melanoma Who Are Candidates for Neoadjuvant Therapy (MK-3475-02C/KEYMAKER-U02) · 102 trials list this drug (23 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04919369Phase 1 · completed All-Trans Retinoic Acid (ATRA) and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer · 102 trials list this drug (23 active) | — | — | Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05999812Phase 2 · active not recruiting Clinical Trial of All-trans-retinoic Acid, Bevacizumab and Atezolizumab in Colorectal Cancer · 102 trials list this drug (23 active) | — | — | Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688140Phase 3 · completed Study for Patients With Newly Diagnosed, High-risk Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04305054Phase 1/Phase 2 · completed Substudy 02B: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With First Line (1L) Advanced Melanoma (MK-3475-02B/KEYMAKER-U02) · 102 trials list this drug (23 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01409161Phase 2 · recruiting Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07586813Phase 2 · recruiting Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors · 102 trials list this drug (23 active) | — | — | Digestive System Neoplasm,Malignant Pancreatic Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07586826Phase 2 · recruiting Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors · 102 trials list this drug (23 active) | — | — | Malignant Breast Neoplasm,Malignant Lung Neoplasm,Lung Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06706401Phase 3 · recruiting Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma · 102 trials list this drug (23 active) | — | — | Malignant Laryngeal Neoplasm,Malignant Hypopharyngeal Neoplasm,Malignant Oropharyngeal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06536413Phase 1/Phase 2 · recruiting ATRA and Carfilzomib in Plasma Cell Myeloma Patients · 102 trials list this drug (23 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07503730Phase 3 · recruiting Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL). · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05345002Phase 2 · recruiting All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma · 102 trials list this drug (23 active) | — | — | Glioma,Astrocytoma,Oligodendroglioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339740Phase 3 · active not recruiting Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06358677Phase 2 · recruiting Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Patients With Solid Tumors · 102 trials list this drug (23 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06484920Phase 2 · recruiting A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL · 102 trials list this drug (23 active) | — | — | B-Cell Malignant Neoplasm,Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07348107Phase 1 · not yet recruiting ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma. · 102 trials list this drug (23 active) | — | — | Pancreatic Ductal Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04241276Phase 2 · active not recruiting A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer · 102 trials list this drug (23 active) | — | — | Malignant Pancreatic Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07296445Phase 3 · not yet recruiting A Trial to Investigate Whether Oral Arsenic Trioxide Is Similar to Intravenous Arsenic Trioxide in Pharmacokinetics, Safety, and Efficacy (LATITUDE/SDKARS-301) · 102 trials list this drug (23 active) | — | — | Leukemia,Acute Leukemia,Acute Promyelocytic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04113863Phase 2 · terminated Evaluation of ATRA Activity in Combination With Anastrozole in Pre-operative Phase of Operable Early Breast Cancer · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06439888Phase 1/Phase 2 · recruiting Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer · 102 trials list this drug (23 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06731140Phase 2 · recruiting Reverse HER2-negative Immune Resistant Breast Cancer · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02712905Phase 1/Phase 2 · terminated An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06528769Phase 2 · recruiting Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma · 102 trials list this drug (23 active) | — | — | Sarcoma,Leiomyosarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07187505NA · active not recruiting Venetoclax Combined With ATRA and ATO in Hyperleukocytic Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06371274NA · recruiting A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC. · 102 trials list this drug (23 active) | — | — | Triple-Negative Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03031249Phase 1/Phase 2 · enrolling by invitation Efficacy and Safety of ATO Plus ATRA in Nucleophosmin-1 Mutated Acute Myeloid Leukemia · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04700176Phase 2 · terminated A Study of Daratumumab With Pomalidomide, Dexamethasone, and All-Transretinoic Acid in Patients With Multiple Myeloma · 102 trials list this drug (23 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06646666Phase 2 · not yet recruiting ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT · 102 trials list this drug (23 active) | — | — | B-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482451early Phase 1 · unknown Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02942758Phase 2 · terminated Low-dose AZA, Pioglitazone, ATRA Versus Standard-dose AZA in Patients >=60 Years With Refractory AML · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03572387Phase 2 · completed A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment · 102 trials list this drug (23 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04793919Phase 2 · recruiting Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 102 trials list this drug (23 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02403778Phase 2 · completed Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma · 102 trials list this drug (23 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02842827Phase 1/Phase 2 · completed A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001) · 102 trials list this drug (23 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003601Phase 2 · completed Tretinoin With or Without Fenretinide in Treating Patients With Dysplastic Nevus Syndrome · 102 trials list this drug (23 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02751255Phase 1/Phase 2 · completed Daratumumab in Combination With ATRA · 102 trials list this drug (23 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03999684Phase 2 · completed A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma · 102 trials list this drug (23 active) | — | — | Adenoid Cystic Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00492856Phase 3 · completed S0521, Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551460Phase 2 · completed S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02641782Phase 2 · terminated NB2013-HR German (GPOH) / Dutch (DCOG) Trial · 102 trials list this drug (23 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05497310Phase 1/Phase 2 · unknown Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APL · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00866918Phase 3 · completed Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Myeloid Neoplasm,Childhood Acute Promyelocytic Leukemia with t(15;17)(q24.1;q21.2); PML-RARA | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00482833Phase 3 · completed Phase III Trial in Acute Promyelocytic Leukemia Patients · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02200978Phase 4 · completed A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia · 102 trials list this drug (23 active) | — | — | Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05297123Phase 1 · unknown Treatment of Acute Myeloid Leukemia With Arsenic and All-trans Retinoid Acid · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05175508Phase 2/Phase 3 · unknown Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS · 102 trials list this drug (23 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02899169Phase 3 · unknown Treatment of Non-high-risk Acute Promyelocytic Leukemia (APL) With Realgar-Indigo Naturalis Formula (RIF) · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05016349Phase 3 · unknown Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer. · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04433169Phase 2 · unknown All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and Neck · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064557NA · unknown "AIDA" Protocol (LAP 0493) · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064570Phase 2 · unknown AIDA 2000 Guidelines · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02273102Phase 1 · completed Study of TCP-ATRA for Adult Patients With AML and MDS · 102 trials list this drug (23 active) | — | — | Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03307148Phase 1 · completed Stromal TARgeting for PAncreatic Cancer (STAR_PAC) · 102 trials list this drug (23 active) | — | — | Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00617409Phase 2 · completed To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid · 102 trials list this drug (23 active) | — | — | Lung Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02177812Phase 1 · terminated A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML) · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00413166Phase 2 · completed All-trans Retinoic Acid, and Arsenic +/- Idarubicin · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02717884Phase 1/Phase 2 · unknown Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP) · 102 trials list this drug (23 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01237808Phase 3 · completed Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006239Phase 1 · completed Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer · 102 trials list this drug (23 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00151242Phase 2/Phase 3 · completed Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01820624Phase 1 · completed Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia · 102 trials list this drug (23 active) | — | — | Adult Acute Megakaryoblastic Leukemia,Adult Acute Myeloid Leukemia,Adult Acute Myeloid Leukemia with Maturation+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00151255Phase 3 · completed All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02401295Phase 1 · completed ATRA, Celecoxib, and Itraconazole as Maintenance · 102 trials list this drug (23 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01226303Phase 3 · unknown Treatment Study for Children and Adolescents With Acute Promyelocitic Leukemia · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01985477Phase 1 · terminated Revlimid / All-Trans Retinoic Acid (ATRA) / Dexamethasone in Relapsed/Refractory Multiple Myeloma · 102 trials list this drug (23 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00867672Phase 2 · completed Study of Decitabine Alone or in Combination With Valproic Acid and All-trans Retinoic Acid in Acute Myeloid Leukemia · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048086Phase 2 · withdrawn 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) · 102 trials list this drug (23 active) | — | — | Neuroendocrine Tumor,Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00892190Phase 1 · completed Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome · 102 trials list this drug (23 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00528450Phase 2 · terminated Tretinoin and Arsenic Trioxide With or Without Idarubicin in Treating Patients With Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01067274Phase 3 · withdrawn ALFA-0703 Study in Older Patients With Acute Myeloblastic Leukemia (AML) · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02261779Phase 1/Phase 2 · unknown Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00175812Phase 1/Phase 2 · completed Differentiation Induction in Acute Myelogenous Leukemia · 102 trials list this drug (23 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278861Phase 2 · completed Oral Isotretinoin Versus Topical Tretinoin for Actinic Keratosis · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00408278Phase 4 · completed Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005) · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00504764Phase 4 · completed Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO) · 102 trials list this drug (23 active) | — | — | Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01349556NA · withdrawn Prevention of Drug Rash From Certain Cancer Therapies Using Tretinoin Cream · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00276601Phase 2 · completed Combination Chemotherapy in Treating Patients With Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514293Phase 2 · unknown Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · 102 trials list this drug (23 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002658Phase 3 · unknown Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005863Phase 3 · completed Combination Chemotherapy With or Without Filgrastim and/or Tretinoin in Treating Patients With Acute Myeloid Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005823Phase 3 · completed Intensive Compared With Nonintensive Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome · 102 trials list this drug (23 active) | — | — | Leukemia,Myelodysplastic Syndrome,Myelodysplastic/Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005825Phase 2 · unknown Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer · 102 trials list this drug (23 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002701Phase 3 · unknown Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00100906Phase 2 · completed Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer · 102 trials list this drug (23 active) | — | — | Malignant Kidney Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017225Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Neuroblastoma · 102 trials list this drug (23 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01161550Phase 1 · completed Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003934Phase 3 · completed Tretinoin, Cytarabine, and Daunorubicin Hydrochloride With or Without Arsenic Trioxide Followed by Tretinoin With or Without Mercaptopurine and Methotrexate in Treating Patients With Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Adult Acute Myeloid Leukemia,Adult Acute Promyelocytic Leukemia,Childhood Acute Promyelocytic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00601796Phase 2 · completed Vaccine Therapy, Tretinoin, and Cyclophosphamide in Treating Patients With Metastatic Lung Cancer · 102 trials list this drug (23 active) | — | — | Malignant Lung Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006220Phase 1/Phase 2 · terminated Arsenic Trioxide With or Without Tretinoin in Treating Patients With Hematologic Cancer That Has Not Responded to Previous Therapy · 102 trials list this drug (23 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016159Phase 2 · completed Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00326170Phase 2 · completed Phase II 5-Azacytidine Plus VPA Plus ATRA · 102 trials list this drug (23 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002479Phase 2 · completed Tretinoin in Treating Patients With Mycosis Fungoides or Sezary Syndrome · 102 trials list this drug (23 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00533169Phase 1 · terminated ZD6474 Alone and in Combination With Retinoic Acid in Pediatric Neuroblastoma · 102 trials list this drug (23 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00136461Phase 2 · completed A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) · 102 trials list this drug (23 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003598NA · completed UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia · 102 trials list this drug (23 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048645Phase 2 · completed Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer · 102 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01041833Phase 3 · unknown Effect of All-trans Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-line Treatment of Patients With Advanced Non-small Cell Lung Cancer and Expression of RAR-alfa and RAR-beta as Response Biomarker · 102 trials list this drug (23 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00599937Phase 3 · completed APL93: Timing of CxT and Role of Maintenance · 102 trials list this drug (23 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00195156Phase 1 · terminated Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies · 102 trials list this drug (23 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |